Shannon Dahl SB '99
Chief Scientific Officer and Company Builder
Other Affiliations : PhD - Duke
Company builder in biologics and cell & gene therapy, who advances products & companies from discovery to commercialization. Drives a clear path forward at every step of company development, with notable results advancing innovative products into the clinic and through global Phase III trials, setting FDA regulatory precedents, and establishing new payment paths with CMS. Named to the 2018 PharmaVOICE 100 list of the most transformational, influential, and inspirational leaders in the global healthcare and life sciences industry.